MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0285917

Медицинская библиотека · PloS one · 2023

Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.

Pérez-Recio Sandra, Grijota-Camino Maria D, Anibarro Luis, Rabuñal-Rey Ramón, Sabria Josefina, Gijón-Vidaurreta Paloma, Pomar Virginia, García-Gasalla Mercedes, Domínguez-Castellano Ángel, Trigo Matilde, Santos María Jesús, Cebollero Alba, Rodríguez Sara, Moga Esther, Penas-Truque Anton, Martos Carmen, Ruiz-Serrano M Jesús, Garcia-de-Cara Erika I, Alcaide Fernando, Santin Miguel

Многоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Interferon-y Release Assays (IGRA) reversions have been reported in different clinical scenarios for the diagnosis of tuberculosis (TB) infection. This study aimed to determine the rate of QuantiFERON-TB Gold Plus (QFT-Plus) reversions during contact investigation as a potential strategy to reduce the number of preventive treatments.

METHODS

Prospective, multicentre cohort study of immunocompetent adult contacts of patients with pulmonary TB tested with QFT-Plus. Contacts with an initial positive QFT-Plus (QFT-i) underwent a second test within 4 weeks (QFT-1), and if negative, underwent a repeat test 4 weeks later (QFT-2). Based on the QFT-2 result, we classified cases as sustained reversion if they remained negative and as temporary reversion if they turned positive.

RESULTS

We included 415 contacts, of whom 96 (23.1%) had an initial positive test (QFT-i). Following this, 10 had negative QFT-1 results and 4 (4.2%) of these persisted with a negative result in the QFT-2 (sustained reversions). All four sustained reversions occurred in contacts with IFN-γ concentrations between ≥0.35 and ≤0.99 IU•mL-1 in one or both QFT-i tubes.

CONCLUSION

In this study, TB contact investigations rarely reveal QFT-Plus reversion. These results do not support retesting cases with an initial positive result to reduce the number of preventive treatments.

Для цитирования: Pérez-Recio Sandra, Grijota-Camino Maria D, Anibarro Luis, Rabuñal-Rey Ramón, Sabria Josefina, Gijón-Vidaurreta Paloma, Pomar Virginia, García-Gasalla Mercedes, Domínguez-Castellano Ángel, Trigo Matilde, Santos María Jesús, Cebollero Alba, Rodríguez Sara, Moga Esther, Penas-Truque Anton, Martos Carmen, Ruiz-Serrano M Jesús, Garcia-de-Cara Erika I, Alcaide Fernando, Santin Miguel. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.. PloS one. 2023. DOI: 10.1371/journal.pone.0285917.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.